Condition category
Mental and Behavioural Disorders
Date applied
29/06/2006
Date assigned
27/07/2006
Last edited
04/02/2010
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Rami Jumnoodoo

ORCID ID

Contact details

Park Royal Centre for Mental Health
Acton Lane
Central Way
London
NW10 7NS
United Kingdom
+44 (0)20 8955 4444
rami.jumnoodoo@nhs.net

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

JUMRC6002

Study information

Scientific title

Acronym

RPGP

Study hypothesis

Following an eight week Relapse Prevention (RP) programme, service users have:
1. Decrease in admission rates
2. Decrease in length of stay following admission
3. Increase in the attendance rates of hospital appointments
4. Increased their self-efficacy
5. Greater knowledge in medication, support services and illnesses
6. Improved quality of life
7. Reduced severity of symptomatology

It is expected that there will be a significant difference in these variables between individuals receiving the RP programme (treatment group) and individuals receiving treatment as usual (comparison group) that this is maintained at three and six months follow-up.

Ethics approval

COREC - Brent Medical Ethics Committee

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Treatment

Patient information sheet

Condition

Schizophrenia

Intervention

Relapse prevention programme as opposed to treatment as usual

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

1. Increased self-efficacy
2. Greater knowledge in medication, support services and illnesses
3. Improved quality of life
4. Reduced severity of symptomatology

Secondary outcome measures

1. Decrease in admission rates
2. Decrease in length of stay following admission
3. Increase in the attendance rates of hospital appointments

Overall trial start date

11/09/2006

Overall trial end date

11/05/2007

Reason abandoned

Eligibility

Participant inclusion criteria

1. Newly diagnosed by a Community Psychiatric Nurse (CPN)
2. Age group 18-45, men and women
3. Have a diagnosis of schizophrenia (ICD 10-F20)
4. Sufficiently stable to take part in the programme
5. Assessment conducted by CPN
6. Living in the community
7. Be able to consent to participate
8. Be on a therapeutic dose of anti-psychotic medication

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

96

Participant exclusion criteria

1. Patients who do not speak English or cannot use an interpreter because this will be another confounder to the study
2. Patients with drug dependency as indicated by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)although alcohol/drug abusers will still be eligible for the study. The DSM- IV criterion for abuse is very restrictive and would capture most alcohol/drug use by mental health service users. The CPN’s will be provided with this to make this assessment
3. Organic brain diseases (e.g. dementia) as assessed by the psychiatrist. The psychiatrist will be asked to assess whether the patient is capable of giving informed consent and understanding what they have been asked to do
4. Patients who have previously been treated with RP
5. Patients who refuse to provide consent

Recruitment start date

11/09/2006

Recruitment end date

11/05/2007

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Park Royal Centre for Mental Health
London
NW10 7NS
United Kingdom

Sponsor information

Organisation

Brent Mental Health Service (UK)

Sponsor details

32 London Road
Wembley
Middlesex
HA9 7SS
United Kingdom

Sponsor type

Hospital/treatment centre

Website

Funders

Funder type

Hospital/treatment centre

Funder name

Funded by Brent Mental Health Service and The Brent Relapse Prevention Programme (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18768007

Publication citations

  1. Results

    Foster JH, Jumnoodoo R, Relapse prevention in serious and enduring mental illness: a pilot study., J Psychiatr Ment Health Nurs, 2008, 15, 7, 552-561, doi: 10.1111/j.1365-2850.2008.01265.x.

Additional files

Editorial Notes